Sarcopenia and recovery from Disuse-Induced Atrophy
肌肉减少症和废用性萎缩的恢复
基本信息
- 批准号:10549727
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-01-01 至 2025-12-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAcuteAddressAgeAge MonthsAgingAnimal ModelAnimalsAtrophicAttenuatedBed restClinicalCuesDataDenervationDevelopmentDietDietary SupplementationDisuse AtrophyDoseElderlyEuthanasiaEventFemaleFish OilsGene ExpressionGenetic TranscriptionGoalsGrowthHindlimb SuspensionHumanHybridsImmobilizationImpairmentIndividualInjuryLength of StayLife StyleLimb structureMedicalModelingMolecularMonitorMotorMuscleMuscle FibersMuscle functionMuscular AtrophyNerveNeuromuscular JunctionNorwayOlder PopulationOmega-3 Fatty AcidsOutputPathway interactionsPatientsPersonsPharmacologic SubstanceProcessRattusRecoveryRecovery of FunctionRehabilitation therapyResearchRodentSkeletal MuscleSupplementationSystemTestingTimeTraumaTraumatic injuryUnited States Department of Veterans AffairsVeteransWeight-Bearing stateage-related muscle lossagedaging populationcohortdietarydisabilityeffective therapyeffectiveness testingfallsfatty acid supplementationfrailtyfunctional lossimpaired capacityimprovedinsightmalemechanical loadmiddle agemuscle formmuscle strengthneuralpreventprogramsresistance exercisesarcopeniaskeletal muscle wastingtherapeutically effectivetranslational applications
项目摘要
The aging process is associated with a progressive decline in motor function that has a major impact on the
ability to maintain an independent lifestyle; contributing to the frailty and loss of mobility observed in older
adults. Aging is also associated with a reduced capacity to respond to growth cues derived from activities
such as resistance exercise and return to weight bearing following inactivity or injury. An inability to respond
to mechanical loading or to restore muscle size following extended periods of bed rest or inactivity
accelerates the progression of sarcopenia and contributes to the loss of functional mobility, independence
and the onset of frailty. The proposed research is of particular relevance to the Veteran’s Administration
since a significant number of patients within the system will suffer skeletal muscle atrophy as a
consequence of bed rest, immobilization, or neural trauma. Further, the effects of muscle atrophy are more
debilitating with age resulting in longer hospital stays, a decrease in mobility and independence, an increase
in falls, and long-term disability. Since the population of older veterans is rising, this issue represents a
growing medical and monetary concern for the VA. Thus, the long-term objective of the research outlined in
this proposal is to address an important unmet clinical need through the development of effective therapies
for the enhancement of muscle recovery following atrophy. Based on our recent findings, we hypothesize
that the lack of functional recovery following disuse-induced atrophy in aged animals is related, in part, to an
increase in neuromuscular junction impairment during disuse that worsens upon reloading. Recent studies
suggest that diet supplementation with long-chain omega-3 fatty acids has benefits to muscle mass and
force output, however, further study is needed. It is the objective of this proposal to test the ability of dietary
supplementation with fish oil to prevent the loss of muscle mass and function with age and enhance the
recovery of muscle mass and function following disuse-induced atrophy. These studies will use an animal
model that has outstanding translational application to humans: the Fischer Brown Norway F1 hybrid rat
(FBNF1). Completion of the specific aims outlined in this proposal will provide data on whether fish oil is a
potential treatment for sarcopenia and/or can enhance the recovery of muscle mass and function from
disuse atrophy. The studies will also provide information on the mechanisms involved in sarcopenia and
age-associated loss of growth capacity. In specific aim 1 we will test the ability of fish oil supplementation to
enhance the recovery of muscle from atrophy induced by hindlimb unloading in old male FBNF1 rats. Old
rats will receive an 8-week loading dose of dietary fish oil supplementation prior to hindlimb unloading,
which will continue throughout the 14 days of unloading and 14 days of reloading. In specific aim 2 we will
determine if 9 months of dietary fish oil supplementation can prevent or attenuate the loss of muscle mass
and strength in male and female rats. Dietary supplementation will begin at 22 months of age in males and
20 months of age in females; ages at which significant loss of hind limb muscle mass and function are not
measurable. Rats will be euthanized at multiple time points between 22 and 31 months in males (20 to 29
months in females) to monitor the loss of muscle mass and strength and to examine potential molecular and
cellular mechanisms of sarcopenia and potential mechanisms of action of the fish oil treatment.
衰老过程与运动功能的逐渐下降有关,这对身体产生重大影响。
保持独立生活方式的能力;导致老年人虚弱和行动不便
成年人。衰老还与对活动产生的生长线索做出反应的能力下降有关
例如抵抗运动以及在不活动或受伤后恢复负重。无法回应
机械负荷或在长时间卧床休息或不活动后恢复肌肉大小
加速肌肉减少症的进展并导致功能活动能力和独立性的丧失
以及虚弱的开始。拟议的研究与退伍军人管理局特别相关
因为系统内的大量患者将遭受骨骼肌萎缩的困扰
卧床休息、固定或神经损伤的后果。此外,肌肉萎缩的影响更大
随着年龄的增长而衰弱,导致住院时间延长、活动能力和独立性下降、
跌倒和长期残疾。由于老年退伍军人的数量不断增加,这个问题代表了一个
对退伍军人管理局日益增长的医疗和财务担忧。因此,该研究的长期目标概述于
该提案旨在通过开发有效的疗法来解决重要的未满足的临床需求
用于增强萎缩后的肌肉恢复。根据我们最近的发现,我们假设
老年动物废用性萎缩后缺乏功能恢复部分与
废弃期间神经肌肉接头损伤增加,重新加载时会恶化。最近的研究
表明饮食中补充长链 omega-3 脂肪酸对肌肉质量和
然而,力量输出还需要进一步研究。该提案的目的是测试饮食的能力
补充鱼油可防止肌肉质量和功能随着年龄的增长而损失,并增强
废用性萎缩后肌肉质量和功能的恢复。这些研究将使用动物
对人类具有杰出转化应用的模型:Fischer Brown 挪威 F1 杂交大鼠
(FBNF1)。完成本提案中概述的具体目标将提供有关鱼油是否是一种
肌肉减少症的潜在治疗方法和/或可以增强肌肉质量和功能的恢复
废用性萎缩。这些研究还将提供有关肌肉减少症和肌肉减少症所涉及机制的信息。
与年龄相关的生长能力丧失。在具体目标 1 中,我们将测试补充鱼油的能力
增强老年雄性 FBNF1 大鼠后肢卸荷引起的肌肉萎缩的恢复。老的
大鼠在后肢卸载前将接受为期 8 周的负荷剂量膳食鱼油补充剂,
这将持续整个卸货的 14 天和装货的 14 天。在具体目标 2 中,我们将
确定 9 个月的膳食鱼油补充剂是否可以预防或减轻肌肉质量的损失
以及雄性和雌性大鼠的力量。男性和女性从 22 个月大时开始膳食补充剂
女性20个月大;后肢肌肉质量和功能未显着丧失的年龄
可测量的。雄性大鼠将在 22 至 31 个月(20 至 29 个月)之间的多个时间点被安乐死。
女性几个月)监测肌肉质量和力量的损失,并检查潜在的分子和
肌肉减少症的细胞机制和鱼油治疗的潜在作用机制。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sue C Bodine其他文献
Sue C Bodine的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sue C Bodine', 18)}}的其他基金
MoTrPAC: UC Preclinical Animal Study Site - Supplement
MoTrPAC:UC 临床前动物研究网站 - 补充材料
- 批准号:
10746582 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Sarcopenia and recovery from Disuse-Induced Atrophy
肌肉减少症和废用性萎缩的恢复
- 批准号:
10361323 - 财政年份:2022
- 资助金额:
-- - 项目类别:
The Role of Intramuscular Lipids in Muscle Anabolic Resistance
肌内脂质在肌肉合成代谢抵抗中的作用
- 批准号:
9461483 - 财政年份:2017
- 资助金额:
-- - 项目类别:
The Role of Intramuscular Lipids in Muscle Anabolic Resistance
肌内脂质在肌肉合成代谢抵抗中的作用
- 批准号:
9128358 - 财政年份:2016
- 资助金额:
-- - 项目类别:
Mechanisms Involved in Age-Related Loss of Muscle Mass and Growth Response
与年龄相关的肌肉质量损失和生长反应的机制
- 批准号:
8548959 - 财政年份:2012
- 资助金额:
-- - 项目类别:
Mechanisms Involved in Age-Related Loss of Muscle Mass and Growth Response
与年龄相关的肌肉质量损失和生长反应的机制
- 批准号:
8838187 - 财政年份:2012
- 资助金额:
-- - 项目类别:
Mechanisms Involved in Age-Related Loss of Muscle Mass and Growth Response
与年龄相关的肌肉质量损失和生长反应的机制
- 批准号:
8277635 - 财政年份:2012
- 资助金额:
-- - 项目类别:
Mechanisms Involved in Age-Related Loss of Muscle Mass and Growth Response
与年龄相关的肌肉质量损失和生长反应的机制
- 批准号:
8839282 - 财政年份:2012
- 资助金额:
-- - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Standard Grant














{{item.name}}会员




